A detailed history of Sbi Securities Co., Ltd. transactions in Liquidia Corp stock. As of the latest transaction made, Sbi Securities Co., Ltd. holds 3 shares of LQDA stock, worth $85. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3
Previous 120 97.5%
Holding current value
$85
Previous $1.5 Million 95.45%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 04, 2025

SELL
$12.06 - $28.85 $1,411 - $3,375
-117 Reduced 97.5%
3 $68,000
Q2 2025

Aug 07, 2025

BUY
$11.99 - $19.3 $1,402 - $2,258
117 Added 3900.0%
120 $1.5 Million
Q1 2025

May 01, 2025

BUY
$11.36 - $16.5 $34 - $49
3 New
3 $44,000

Others Institutions Holding LQDA

About Liquidia Corp


  • Ticker LQDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,362,300
  • Market Cap $1.84B
  • Description
  • Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...
More about LQDA
Track This Portfolio

Track Sbi Securities Co., Ltd. Portfolio

Follow Sbi Securities Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sbi Securities Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Sbi Securities Co., Ltd. with notifications on news.